Gristina, Valerio
Russo, Tancredi Didier Bazan
Barraco, Nadia
Gottardo, Andrea
Pepe, Francesco
Russo, Gianluca
Fulfaro, Fabio
Incorvaia, Lorena
Badalamenti, Giuseppe
Troncone, Giancarlo
Malapelle, Umberto
Russo, Antonio
Bazan, Viviana
Galvano, Antonio
Article History
Received: 29 May 2024
Accepted: 12 September 2024
First Online: 27 September 2024
Declarations
:
: F.P. received personal fees (as speaker bureau or advisor) from Menarini. G.T. received personal fees (as speaker bureau or advisor) from Roche, MSD, Pfizer, Boehringer Ingelheim, Eli Lilly, BMS, GSK, Menarini, AstraZeneca, Amgen and Bayer, all unrelated to the current work. U.M. received personal fees (as consultant and/or speaker bureau) from Boehringer Ingelheim, Roche, MSD, Amgen, Thermo Fisher Scientific, Eli Lilly, Diaceutics, GSK, Merck and AstraZeneca, Janssen, Diatech, Novartis and Hedera, all unrelated to the current work. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by Palermo 1 Institutional Ethic Review Board (Statement No. 02/2020, approved on 19 February 2020, AIFA code CE 150109).
: Informed consent was obtained from all subjects involved in the study.